Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Lactic Acidosis Interferes With Toxicity of Perifosine to Colorectal Cancer Spheroids: Multimodal Imaging Analysis

B. Pavlatovská, M. Machálková, P. Brisudová, A. Pruška, K. Štěpka, J. Michálek, T. Nečasová, P. Beneš, J. Šmarda, J. Preisler, M. Kozubek, J. Navrátilová,

. 2020 ; 10 (-) : 581365. [pub] 20201204

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc21001603

Colorectal cancer (CRC) is a disease with constantly increasing incidence and high mortality. The treatment efficacy could be curtailed by drug resistance resulting from poor drug penetration into tumor tissue and the tumor-specific microenvironment, such as hypoxia and acidosis. Furthermore, CRC tumors can be exposed to different pH depending on the position in the intestinal tract. CRC tumors often share upregulation of the Akt signaling pathway. In this study, we investigated the role of external pH in control of cytotoxicity of perifosine, the Akt signaling pathway inhibitor, to CRC cells using 2D and 3D tumor models. In 3D settings, we employed an innovative strategy for simultaneous detection of spatial drug distribution and biological markers of proliferation/apoptosis using a combination of mass spectrometry imaging and immunohistochemistry. In 3D conditions, low and heterogeneous penetration of perifosine into the inner parts of the spheroids was observed. The depth of penetration depended on the treatment duration but not on the external pH. However, pH alteration in the tumor microenvironment affected the distribution of proliferation- and apoptosis-specific markers in the perifosine-treated spheroid. Accurate co-registration of perifosine distribution and biological response in the same spheroid section revealed dynamic changes in apoptotic and proliferative markers occurring not only in the perifosine-exposed cells, but also in the perifosine-free regions. Cytotoxicity of perifosine to both 2D and 3D cultures decreased in an acidic environment below pH 6.7. External pH affects cytotoxicity of the other Akt inhibitor, MK-2206, in a similar way. Our innovative approach for accurate determination of drug efficiency in 3D tumor tissue revealed that cytotoxicity of Akt inhibitors to CRC cells is strongly dependent on pH of the tumor microenvironment. Therefore, the effect of pH should be considered during the design and pre-clinical/clinical testing of the Akt-targeted cancer therapy.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21001603
003      
CZ-PrNML
005      
20210126092812.0
007      
ta
008      
210105s2020 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fonc.2020.581365 $2 doi
035    __
$a (PubMed)33344237
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Pavlatovská, Barbora $u Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czechia.
245    10
$a Lactic Acidosis Interferes With Toxicity of Perifosine to Colorectal Cancer Spheroids: Multimodal Imaging Analysis. / $c B. Pavlatovská, M. Machálková, P. Brisudová, A. Pruška, K. Štěpka, J. Michálek, T. Nečasová, P. Beneš, J. Šmarda, J. Preisler, M. Kozubek, J. Navrátilová,
520    9_
$a Colorectal cancer (CRC) is a disease with constantly increasing incidence and high mortality. The treatment efficacy could be curtailed by drug resistance resulting from poor drug penetration into tumor tissue and the tumor-specific microenvironment, such as hypoxia and acidosis. Furthermore, CRC tumors can be exposed to different pH depending on the position in the intestinal tract. CRC tumors often share upregulation of the Akt signaling pathway. In this study, we investigated the role of external pH in control of cytotoxicity of perifosine, the Akt signaling pathway inhibitor, to CRC cells using 2D and 3D tumor models. In 3D settings, we employed an innovative strategy for simultaneous detection of spatial drug distribution and biological markers of proliferation/apoptosis using a combination of mass spectrometry imaging and immunohistochemistry. In 3D conditions, low and heterogeneous penetration of perifosine into the inner parts of the spheroids was observed. The depth of penetration depended on the treatment duration but not on the external pH. However, pH alteration in the tumor microenvironment affected the distribution of proliferation- and apoptosis-specific markers in the perifosine-treated spheroid. Accurate co-registration of perifosine distribution and biological response in the same spheroid section revealed dynamic changes in apoptotic and proliferative markers occurring not only in the perifosine-exposed cells, but also in the perifosine-free regions. Cytotoxicity of perifosine to both 2D and 3D cultures decreased in an acidic environment below pH 6.7. External pH affects cytotoxicity of the other Akt inhibitor, MK-2206, in a similar way. Our innovative approach for accurate determination of drug efficiency in 3D tumor tissue revealed that cytotoxicity of Akt inhibitors to CRC cells is strongly dependent on pH of the tumor microenvironment. Therefore, the effect of pH should be considered during the design and pre-clinical/clinical testing of the Akt-targeted cancer therapy.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Machálková, Markéta $u Department of Chemistry, Faculty of Science, Masaryk University, Brno, Czechia.
700    1_
$a Brisudová, Petra $u Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czechia.
700    1_
$a Pruška, Adam $u Department of Chemistry and Applied Biosciences, ETH Zurich, Zurich, Switzerland.
700    1_
$a Štěpka, Karel $u Centre for Biomedical Image Analysis, Faculty of Informatics, Masaryk University, Brno, Czechia.
700    1_
$a Michálek, Jan $u Centre for Biomedical Image Analysis, Faculty of Informatics, Masaryk University, Brno, Czechia.
700    1_
$a Nečasová, Tereza $u Centre for Biomedical Image Analysis, Faculty of Informatics, Masaryk University, Brno, Czechia.
700    1_
$a Beneš, Petr $u Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czechia. Center for Biological and Cellular Engineering, International Clinical Research Center, St. Anne's University Hospital, Brno, Czechia.
700    1_
$a Šmarda, Jan $u Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czechia.
700    1_
$a Preisler, Jan $u Department of Chemistry, Faculty of Science, Masaryk University, Brno, Czechia.
700    1_
$a Kozubek, Michal $u Centre for Biomedical Image Analysis, Faculty of Informatics, Masaryk University, Brno, Czechia.
700    1_
$a Navrátilová, Jarmila $u Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czechia. Center for Biological and Cellular Engineering, International Clinical Research Center, St. Anne's University Hospital, Brno, Czechia.
773    0_
$w MED00182989 $t Frontiers in oncology $x 2234-943X $g Roč. 10, č. - (2020), s. 581365
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33344237 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20210105 $b ABA008
991    __
$a 20210126092808 $b ABA008
999    __
$a ind $b bmc $g 1613947 $s 1121887
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 10 $c - $d 581365 $e 20201204 $i 2234-943X $m Frontiers in oncology $n Front Oncol $x MED00182989
LZP    __
$a Pubmed-20210105

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...